21.12.2023 07:30:06 - dpa-AFX: GNW-Adhoc: Global Bioenergies specifies the schedule of its new biobased isobutene plant for cosmetics
PRESS RELEASE
Global Bioenergies specifies the schedule of its new biobased isobutene plant
for cosmetics
Evry, 21 December 2023 - 07:30 a.m.: Global Bioenergies (FR0011052257 - ALGBE),
a player in industrial biotechnology, announces that the provisional schedule
for the construction and commissioning of its new plant by 2027 is becoming
clearer. The production technology used has been determined, and will be based
on the so-called "direct pathway" process, with total integration of the
production chain and minimization of input requirements. The finalization of the
basic engineering design, concurrent with the signing of the first tranche of
financing for the plant, is expected in summer 2024. This first tranche will
include part of the EUR16.4 million financing awarded by Bpifrance as part of the
France 2030 plan. Once completed, the front end engineering design (FEED) will
be carried out in order to finalize preparation for the construction of the
plant which will take place between 2025 and 2027 on the French territory.
This new plant will be the first in the world to convert plant-based resources
into isobutene derivatives on a large scale, bearing specific high-performance
properties. In the cosmetics market, the products will be marketed under the
Isonaturane(TM) brand name, with applications ranging from make-up to skin care.
Roland Desvignes, Industrial Director of Global Bioenergies, comments: "I joined
Global Bioenergies last July to implement this unique technology at the
crossroads of industrial biotechnology and green chemistry. The project, already
supported by the French government through a EUR16.4m financing, is progressing
well and is taken care of by two engineering companies, each specialized in one
of these two fields."
This plant will also kick-start the production of sustainable aviation fuels
(SAF), a market for which Global Bioenergies obtained ASTM certification last
June and will open the door to the construction of multiple larger plants
focused on this application. In this context, the Group recently initiated a
plan to develop another production site, dimensioned at several tens of thousand
tons specifically dedicated to SAF, with commissioning forecasted in 2030, at
the time the European mandate expands to 6% SAF in all planes taking off from
European airports.
About GLOBAL BIOENERGIES
Global Bioenergies substitutes products of fossil origin with products of
natural origin. In their quest for naturalness without compromising on
performance, the cosmetics players are the Company's first customers. By 2027,
the Company will be operating its innovative process in a large-scale plant. By
2030, the Company plans to become a leader in the huge emerging market for
sustainable aviation fuels, in order to fight against global warming. Global
Bioenergies is listed on Euronext Growth in Paris (FR0011052257 - ALGBE).
L'Oréal is its largest shareholder, with a 13.5% stake.
Contacts
+-------------------------------+ +--------------------------------------------+
| | | |
| | | |
|GLOBAL BIOENERGIES | | |
|+33 (0)1 64 98 20 50 | | |
|invest@global-bioenergies.com | |NewCap - Investor relations |
|(mailto:invest@global- | | |
|bioenergies.com) | |Louis-Victor Delouvrier |
| | |Quentin Massé |
| | |globalbioenergies@newcap.eu |
| | |(mailto:globalbioenergies@newcap.eu) |
|Follow our news | | |
| | |+33 (0)1 44 71 94 94 |
| | | |
| | | |
|Receive information about | | |
|Global Bioenergies directly by | |NewCap - Media relations |
|subscribing to our news feed on| | |
|https://www.global- | | |
|bioenergies.com/inscription- | | |
|newsletter/ | |Nicolas Merigeau |
| | |globalbioenergies@newcap.eu |
| | |+33 (0)1 44 71 94 98 |
| | | |
|Follow us on LinkedIn | | |
|Global Bioenergies | | |
|(https://www.linkedin.com/compa| | |
|ny/global-bioenergies) | | |
| | | |
+-------------------------------+ +--------------------------------------------+
Â